Other income, net (Note 6)
Merck & Co. Other income, net (Note 6) increased by 68.1% to -$138.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 494.3%, from $35.00M to -$138.00M. Over 3 years (FY 2021 to FY 2025), Other income, net (Note 6) shows a downward trend with a -51.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
Positive values indicate non-core gains, while negative values indicate non-core losses or interest burdens.
Detailed definition
This captures income or expenses that are not part of the company's core business operations, such as interest income, f...
Peer comparison
Standard line item found in the non-operating section of the income statement for most corporations.
other_other_nonoperating_income_expenseHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $103.00M | $450.00M | $334.00M | -$708.00M | -$438.00M | -$429.00M | $0.00 | -$89.00M | -$172.00M | -$126.00M | -$78.00M | $33.00M | -$42.00M | $162.00M | $35.00M | $7.00M | $238.00M | -$432.00M | -$138.00M |
| QoQ Change | — | +336.9% | -25.8% | -312.0% | +38.1% | +2.1% | +100.0% | — | -93.3% | +26.7% | +38.1% | +142.3% | -227.3% | +485.7% | -78.4% | -80.0% | >999% | -281.5% | +68.1% |
| YoY Change | — | — | — | — | -525.2% | -195.3% | -100.0% | +87.4% | +60.7% | +70.6% | — | +137.1% | +75.6% | +228.6% | +6.1% | +116.7% | +46.9% | — | -494.3% |
Business Segments
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Pharmaceutical | -$14.00M | -$27.00M | $163.00M | -$49.00M | -$21.00M | -$60.00M | $295.00M | -$55.00M |
| Animal Health | $1.00M | $1.00M | -$2.00M | -$1.00M | $0.00 | -$1.00M | — | $0.00 |
| Total | -$42.00M | $162.00M | — | $35.00M | $7.00M | $238.00M | -$432.00M | -$138.00M |
Animal Health, Pharmaceutical were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
Other income, net (Note 6) at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s other income, net (note 6)?
- Merck & Co. (MRK) reported other income, net (note 6) of -$138.00M in Q1 2026.
- How has Merck & Co.'s other income, net (note 6) changed year-over-year?
- Merck & Co.'s other income, net (note 6) decreased by 494.3% year-over-year, from $35.00M to -$138.00M.
- What is the long-term trend for Merck & Co.'s other income, net (note 6)?
- Over 3 years (2021 to 2025), Merck & Co.'s other income, net (note 6) has grown at a -51.6% compound annual growth rate (CAGR), from $1.34B to -$152.00M.
- What does other income, net (note 6) mean?
- Financial gains or losses that fall outside of the company's primary business activities.